Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Klinko Karya Imaji Tbk. (KLIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Klinko Karya Imaji Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Klinko Karya Imaji Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Klinko Karya Imaji Tbk. trades at Rp106 (market cap 126.83B, 217.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Klinko Karya Imaji Tbk. is more actively traded (217.2K versus 96.7K). Which is the better fit depends on your goals.

KLINOBAT
Market Cap
126.83B167.37B
Volume
217.2K96.7K
Lot
2.17K967
Turnover
21.79M23.82M
Average Price
100.34246.34
Value
21.79M23.82M
Indicative Equilibrium Price
106248
Indicative Equilibrium Volume
3441

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KLIN
View details
OBAT
View details

About Klinko Karya Imaji Tbk.

PT Klinko Karya Imaji Tbk (the Company) was established on November 4, 2016 based on Notarial Deed No. 3 by Ribka Avie Alreta, S.H., M.Kn. The Company started its commercial operations in 2017.

Read more on KLIN

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT